PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Marine Operational Trial

13 Mar 2017 07:00

RNS Number : 2131Z
Quadrise Fuels International PLC
13 March 2017
 

13 March 2017

 

Quadrise Fuels International plc

("Quadrise", "QFI'' or the "Company")

 

Marine Operational Trial

 

Quadrise Fuels International plc (AIM:QFI), the emerging supplier of MSAR® emulsion technology and fuel, enabling a low-cost alternative to heavy fuel oil (one of the world's largest fuels markets, comprising over 450 million tonnes per annum) in the global shipping, refining and power generation markets, announces that the Company has been informed by Maersk Line A/S ("Maersk") of a further update relating to the letter of no objection ("LONO") and MSAR® operational trial on the Maersk nominated vessel.

 

Further to the announcement made on 2 March 2017, regarding the unscheduled dry-docking of the MSAR® trial vessel, Maersk is continuing its efforts to move the test vessel into a suitable dry dock.

 

Maersk has however confirmed that the trial has been successful to date and has also indicated that Wärtsilä will carry out a detailed inspection of the test vessel's engine during the next few months to verify and document the performance of the test vessel while operating on MSAR® fuel, with a view to issuing an "Interim LONO" to confirm the fuel is safe and suitable for the Wärtsilä RT-Flex engine type. 

 

Following an operational redeployment of the vessel upon completion of the dry-docking the vessel will not be able to bunker at Algeciras. As a result, the MSAR® trial will be suspended once the remaining MSAR® fuel on the test vessel has been consumed. Maersk is currently considering alternative test vessels within its fleet for a continuation of the MSAR® trial programme - though it is unlikely that the trial will be resumed before Q4 2017. 

 

Maersk has confirmed that it wants to continue to work with Quadrise to explore the commercial options for Marine MSAR® after the issuance of the Interim LONO.

 

Mike Kirk, Executive Chairman of QFI plc, said:

 

"We are clearly disappointed that Maersk will have to suspend the trial for operational reasons that are unrelated to the MSAR® operational trial. However, we are pleased that Maersk has reconfirmed that the trial to date has been successful and that an interim inspection will be completed in the Spring, as originally scheduled.

 

We look forward to receiving the results of the Interim LONO and working with Maersk to pursue the commercial opportunities for MSAR®. The confirmation of the positive trial programme results to date combined with a positive Interim LONO will enable Quadrise to progress its plans for commercialisation of Marine MSAR®".

 

 

 

Niels H Bruus, Head of Future Solutions of Maersk Line A/S, said:

 

"During the MSAR® trial program Maersk has enjoyed a close and professional collaboration with both our technology partner QFI, and supply partner CEPSA, resulting in a smooth operation during which the fuel has performed well.

 

We look forward to continuing our collaborations and will work with QFI to consider the commercial opportunities of MSAR® while we review options for continuing trials aboard other vessels."

 

This announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

For additional information, please contact:

 

Quadrise Fuels International plc +44 (0)20 7031 7321

Mike Kirk

Hemant Thanawala

Jason Miles

 

Smith & Williamson Corporate Finance Limited +44 (0)20 7131 4000

Dr Azhic Basirov

Ben Jeynes

Katy Birkin

 

Peel Hunt LLP +44 (0)20 7418 8900

Richard Crichton

Ross Allister

Chris Burrows

 

FTI Consulting +44 (0)20 3727 1000

Ben Brewerton

Sara Powell

 

 

Notes to Editors

 

QFI has developed MSAR® as a less expensive, cleaner synthetic HFO. Produced using QFI's proprietary technologies and services, MSAR® offers both producers and consumers of the fuel significant economic and environmental advantages. MSAR®, an oil in water emulsion, is made by mixing the residue stream from an oil refinery with water and specialised chemicals in a proprietary production process, instead of diluting the residuals with high value distillate products as in the production of HFO.

 

QFI acts as the technology and service partner to both the producer and the consumer and aims to create value both through licence revenues from the production of fuel and the sale of the chemicals and MSAR® manufacturing systems. The core technology has been developed jointly with AkzoNobel - one of the world's leading surface chemistry companies.

 

The two largest markets for the use of MSAR® as a low cost, efficient and environmentally friendly synthetic HFO are marine bunkering and power generation. Significant work has been carried out to demonstrate the proof of concept in both end-user markets and current work is focused on commercial scale trials the successful conclusion of which will be a significant milestone towards QFI developing sustainable commercial revenues.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDLLFVAVLIFLID
Date   Source Headline
2nd Feb 20217:00 amRNSUpdate re Morocco and Greenfield Energy Projects
1st Feb 20217:00 amRNSUpdate re bioMSAR Testing at Aquafuel Research Ltd
27th Jan 20217:00 amRNSIssue of Equity
21st Jan 20217:00 amRNSJoint Development Agreement - MSC Shipmanagement
6th Jan 20217:00 amRNSIssue of Equity
4th Jan 20217:00 amRNSChange of Registered Office
18th Dec 202011:46 amRNSUpdate re Greenfield MSAR Trial
18th Dec 20207:00 amRNSbioMSAR Testing Update & Collaboration Agreement
15th Dec 20207:00 amRNSLaunch of bioMSAR
3rd Dec 20207:00 amRNSPublication of Americas White Paper
27th Nov 202012:13 pmRNSResult of AGM
27th Nov 20207:00 amRNSAGM Statement
24th Nov 20208:00 amEQSQuadrise Fuels International (QFI): The clean solution to a global problem
2nd Nov 20205:23 pmRNSPosting of Annual Report and Notice of AGM
26th Oct 20207:00 amRNSMorocco Update
5th Oct 20207:00 amRNSFinal Results, Investor Presentation & AGM Notice
7th Sep 20205:56 pmRNSIssue of Equity
7th Sep 20207:00 amRNSNotice of Results, Update and Investor Event
24th Aug 20207:00 amRNSIssue of Share Options
20th Aug 20207:00 amRNSIssue of Equity
18th Aug 20207:22 amRNSGreenfield MSAR Commercial Trial Agreement
17th Aug 20207:00 amRNSPublication of White Paper
17th Jul 20203:59 pmRNSInvestor Presentation
30th Jun 20209:18 amRNSHolding(s) in Company
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:37 pmRNSPrice Monitoring Extension
23rd Jun 20207:00 amRNSIssue of Equity
18th Jun 20207:00 amRNSStatement re MSAR Licensing and Upstream Trial
17th Jun 20201:47 pmRNSStatement re MSAR Licensing
2nd Jun 20207:00 amRNSInvestor Presentation
1st May 20207:00 amRNSFurther Statement re Covid-19 and Update
16th Apr 20202:21 pmRNSIssue of Equity
15th Apr 20207:00 amRNSDirectorate Change
30th Mar 20204:13 pmRNSNew Website
30th Mar 202011:02 amRNSHalf-year Report - Replacement
30th Mar 20207:00 amRNSHalf-year Report
24th Mar 202010:13 amRNSIssue of Equity
16th Mar 20207:00 amRNSStatement re Covid-19 and Morocco Pilot Trial
5th Mar 20209:10 amRNSUpdate on Morocco Pilot Trial
17th Feb 20207:00 amRNSNotice of Interim Results and Business Update
30th Jan 20207:00 amRNSAppointment of New Auditors
15th Jan 20207:00 amRNSDirectorate Changes
16th Dec 20198:38 amRNSDirectorate Change
29th Nov 20194:42 pmRNSResult of AGM
29th Nov 20197:05 amRNSIssue of Warrants
29th Nov 20197:00 amRNSAGM Update
29th Nov 20197:00 amRNSMaterial Transfer & Cooperation Agreement
6th Nov 20195:03 pmRNSPosting of Annual Report and Notice of AGM
10th Oct 20195:42 pmRNSHolding(s) in Company
8th Oct 20197:00 amRNSNew three-year Exclusive Agreement with Nouryon

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.